Heterocyclic modulators of lipid synthesis
US-2024400552-A1 · Dec 5, 2024 · US
US11046668B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11046668-B2 |
| Application number | US-201716083811-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 6, 2017 |
| Priority date | Mar 11, 2016 |
| Publication date | Jun 29, 2021 |
| Grant date | Jun 29, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compounds and compositions of matter are provided that are small molecule antimicrobials. The compounds are selected from JH-144, TH-04 or TH-08 or combinations thereof. Compositions of matter are provided which in an embodiment may comprise a carrier, and in further embodiments may comprise a pharmaceutically acceptable excipient, film, biofilm or edible film. Methods of use are provided in which the composition may be administered to a subject in need thereof, and in an embodiment where the subject has a bacterial infection. Other embodiments provide the composition may be contacted with surface to eliminate or reduce bacteria.
Opening claim text (preview).
What is claimed is: 1. A composition of matter comprising an antimicrobial compound, said composition comprising a compound selected from JA-144, TH-04 or TH-08 or combination thereof, said compound having the following formula: or pharmaceutically acceptable salts thereof. 2. The composition of matter of claim 1 further comprising a carrier. 3. The composition of matter of claim 2 , wherein said carrier comprises a pharmaceutically acceptable excipient. 4. The composition of matter of claim 3 , comprising a composition for topical administration. 5. The composition of matter of claim 3 , comprising a composition for systemic administration. 6. The composition of matter of claim 2 , wherein said carrier comprises a film. 7. The composition of matter of claim 6 , wherein said compound is JA-144. 8. The composition of matter of claim 6 , wherein said film comprises an edible film. 9. The composition of matter of claim 8 , wherein said compound is JA-144. 10. The composition of matter of claim 6 , wherein said film comprises a package. 11. The composition of matter of claim 10 , wherein said compound is TH-4 or TH-8 or combination thereof. 12. A method of treating a subject in need of treatment for a bacterial infection, said method comprising administering to said subject an effective amount of a composition comprising a compound of JA-144, TH-04 or TH-08 or combination thereof, having the following formula: or pharmaceutically acceptable salts thereof. 13. The method of claim 12 , said composition further comprising a carrier. 14. The method of claim 12 , wherein said carrier comprises a pharmaceutically acceptable excipient. 15. The method of claim 12 , wherein said subject is a mammal. 16. The method of claim 12 , wherein said subject is poultry and said bacterial infection comprises a Campylobacteria infection. 17. A method of inhibiting bacterial growth on a surface, the method comprising contacting said surface with a composition of matter comprising an effective amount of a compound of JA-144, TH-04 or TH-08 or combination thereof, having the following formula: or pharmaceutically acceptable salts thereof. 18. The method of claim 17 , wherein said compositions comprises a carrier. 19. The method of claim 18 , wherein said carrier comprises a film. 20. The method of claim 18 , wherein said carrier comprises an edible film.
containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K31/465) · CPC title
Web, sheet or filament bases {; Films; Fibres of the matrix type containing drug (hollow drug-filled fibres A61K9/0092)} · CPC title
Sulfur atoms · CPC title
Antibacterial agents · CPC title
Mouth and digestive tract, i.e. intraoral and peroral administration · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.